Vistin Pharma ASA: Invitation to Q3 2025 conference call

Company Overview - Vistin Pharma ASA (VISTN) is a Norwegian pharmaceutical company specializing in the production of Metformin Hydrochloride (API) and Direct Compressible lubricated granules [2] - The company is a dedicated European Metformin producer, positioning itself as a key supplier to leading pharmaceutical companies [2] Upcoming Financial Results - Vistin Pharma will release its third quarter and year-to-date 2025 results on October 31, 2025 [1] - A conference call for shareholders and interested parties will take place on the same day at 08:30 CET, including a Q&A session following the management discussion [1] Communication Channels - The conference call will be available via web and audio, with specific access points provided for participants [1][2] - For further inquiries, contact information for the CFO, Alexander Karlsen, is available [2]